Ranjan Batra
Company: Locana
Job title: Vice President of Research and Development
Seminars:
Live Q&A 12:30 pm
day: Day Two
Leveraging RNA Targeting CRISPR Therapeutics to Target Myotonic Dystrophy 11:50 am
• Outlining the principles of Locana’s RNA Targeting approach and outlining its use in myotonic dystrophy (DM1) preclinical models and outlining behavioral and molecular biomarkers • Global alternative splicing defects in DM1 to explore a battery of molecular endpoints, and how these correlate with regression of symptoms • Evaluating data across different modalities including Cas9…Read more
day: Day Two